Review





Similar Products

93
ATCC vero cells
Vero Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vero cells/product/ATCC
Average 93 stars, based on 1 article reviews
vero cells - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
MedChemExpress 8 bromo camp
a , Microarray-based gene expression of lipolytic inhibitors from Fig. in purified mouse adipocytes (C57BL/6J male; GSE27017 , PMID: 23967297) from gWAT (WAT Ad, N = 3) and femur–tibia (rBMAT and cBMAT mix—BMAd, N = 3) and human adipocytes (mixed male and female, aged 53–87 years; PMID: 28574591) from subcutaneous adipose tissue (WAT Ad, N = 3) and femoral head (rBMAT and cBMAT mix—BMAd, N = 3). Arrows indicate expression of candidate lipolysis inhibitor G0s2 . b , Ratio of ATGL-inhibitor G0s2 to ATGL ( Pnpla2 ) in purified mouse adipocytes as in a fed chow (6, 14, and 18 months, N = 3 per group) or a high-fat diet (HFD; 6 and 14 months, N = 3/group). c , Ratio in human purified bone marrow stromal cells (BMSCs) from femoral head and adipocytes as in a ( N = 3 per group). d , Ratio in mouse cBMAT-filled CV with males and females combined ( N = 10 ICV PBS, N = 12 ICV leptin, N = 6 ICV leptin + subcutaneous insulin pellet). Dotted line, average value for iWAT. ins, insulin; Lep, leptin. e – h , Female 11–12-week-old WT control littermates and adipocyte-specific G0s2 KO mice (WT fed N = 6, WT 24-h fast N = 5, cKO fed N = 7, cKO fast N = 5). BMAT quantification ( e ) with representative images; bone is shown in light grey with BMAT in dark grey ( f ). Whole CV were rapidly extracted and quartered with immediate placement in lipolysis stimulation buffer containing 5 µM FSK, 10 <t>mM</t> <t>8-bromo</t> or vehicle control (2 × CV per mouse per treatment condition in 150 µl in a 96-well plate). Plates were incubated at 37°C in 5% CO 2 with samples taken for glycerol measurement after 1.5 and 4.0 h ( g ). Percentage change in glycerol release over time relative to vehicle control for cBMAT-filled CV ( h ). i , We treated 10 mg of iWAT per 150 µl in a 96-well plate from the same animals as described in g as a positive control. j , k , Body mass ( j ) and iWAT mass ( k ) are from the same animals. Mean ± standard deviation ( a – e , j and k ). Mean ± s.e.m. ( h and i ). Individual data points represent biological replicates. Two-tailed t -tests ( b ). One-way ANOVA with Tukey’s multiple comparisons test ( c and d ). Two-way ANOVA genotype × fast with Šidák’s multiple comparisons test ( e and k ). Three-way ANOVA genotype × fast × time ( h – j ). *P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001. g created with BioRender.com .
8 Bromo Camp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8 bromo camp/product/MedChemExpress
Average 94 stars, based on 1 article reviews
8 bromo camp - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
MedChemExpress 8 br cgmp
a , Microarray-based gene expression of lipolytic inhibitors from Fig. in purified mouse adipocytes (C57BL/6J male; GSE27017 , PMID: 23967297) from gWAT (WAT Ad, N = 3) and femur–tibia (rBMAT and cBMAT mix—BMAd, N = 3) and human adipocytes (mixed male and female, aged 53–87 years; PMID: 28574591) from subcutaneous adipose tissue (WAT Ad, N = 3) and femoral head (rBMAT and cBMAT mix—BMAd, N = 3). Arrows indicate expression of candidate lipolysis inhibitor G0s2 . b , Ratio of ATGL-inhibitor G0s2 to ATGL ( Pnpla2 ) in purified mouse adipocytes as in a fed chow (6, 14, and 18 months, N = 3 per group) or a high-fat diet (HFD; 6 and 14 months, N = 3/group). c , Ratio in human purified bone marrow stromal cells (BMSCs) from femoral head and adipocytes as in a ( N = 3 per group). d , Ratio in mouse cBMAT-filled CV with males and females combined ( N = 10 ICV PBS, N = 12 ICV leptin, N = 6 ICV leptin + subcutaneous insulin pellet). Dotted line, average value for iWAT. ins, insulin; Lep, leptin. e – h , Female 11–12-week-old WT control littermates and adipocyte-specific G0s2 KO mice (WT fed N = 6, WT 24-h fast N = 5, cKO fed N = 7, cKO fast N = 5). BMAT quantification ( e ) with representative images; bone is shown in light grey with BMAT in dark grey ( f ). Whole CV were rapidly extracted and quartered with immediate placement in lipolysis stimulation buffer containing 5 µM FSK, 10 <t>mM</t> <t>8-bromo</t> or vehicle control (2 × CV per mouse per treatment condition in 150 µl in a 96-well plate). Plates were incubated at 37°C in 5% CO 2 with samples taken for glycerol measurement after 1.5 and 4.0 h ( g ). Percentage change in glycerol release over time relative to vehicle control for cBMAT-filled CV ( h ). i , We treated 10 mg of iWAT per 150 µl in a 96-well plate from the same animals as described in g as a positive control. j , k , Body mass ( j ) and iWAT mass ( k ) are from the same animals. Mean ± standard deviation ( a – e , j and k ). Mean ± s.e.m. ( h and i ). Individual data points represent biological replicates. Two-tailed t -tests ( b ). One-way ANOVA with Tukey’s multiple comparisons test ( c and d ). Two-way ANOVA genotype × fast with Šidák’s multiple comparisons test ( e and k ). Three-way ANOVA genotype × fast × time ( h – j ). *P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001. g created with BioRender.com .
8 Br Cgmp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8 br cgmp/product/MedChemExpress
Average 94 stars, based on 1 article reviews
8 br cgmp - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
MedChemExpress intracellular cgmp pathway
a , Microarray-based gene expression of lipolytic inhibitors from Fig. in purified mouse adipocytes (C57BL/6J male; GSE27017 , PMID: 23967297) from gWAT (WAT Ad, N = 3) and femur–tibia (rBMAT and cBMAT mix—BMAd, N = 3) and human adipocytes (mixed male and female, aged 53–87 years; PMID: 28574591) from subcutaneous adipose tissue (WAT Ad, N = 3) and femoral head (rBMAT and cBMAT mix—BMAd, N = 3). Arrows indicate expression of candidate lipolysis inhibitor G0s2 . b , Ratio of ATGL-inhibitor G0s2 to ATGL ( Pnpla2 ) in purified mouse adipocytes as in a fed chow (6, 14, and 18 months, N = 3 per group) or a high-fat diet (HFD; 6 and 14 months, N = 3/group). c , Ratio in human purified bone marrow stromal cells (BMSCs) from femoral head and adipocytes as in a ( N = 3 per group). d , Ratio in mouse cBMAT-filled CV with males and females combined ( N = 10 ICV PBS, N = 12 ICV leptin, N = 6 ICV leptin + subcutaneous insulin pellet). Dotted line, average value for iWAT. ins, insulin; Lep, leptin. e – h , Female 11–12-week-old WT control littermates and adipocyte-specific G0s2 KO mice (WT fed N = 6, WT 24-h fast N = 5, cKO fed N = 7, cKO fast N = 5). BMAT quantification ( e ) with representative images; bone is shown in light grey with BMAT in dark grey ( f ). Whole CV were rapidly extracted and quartered with immediate placement in lipolysis stimulation buffer containing 5 µM FSK, 10 <t>mM</t> <t>8-bromo</t> or vehicle control (2 × CV per mouse per treatment condition in 150 µl in a 96-well plate). Plates were incubated at 37°C in 5% CO 2 with samples taken for glycerol measurement after 1.5 and 4.0 h ( g ). Percentage change in glycerol release over time relative to vehicle control for cBMAT-filled CV ( h ). i , We treated 10 mg of iWAT per 150 µl in a 96-well plate from the same animals as described in g as a positive control. j , k , Body mass ( j ) and iWAT mass ( k ) are from the same animals. Mean ± standard deviation ( a – e , j and k ). Mean ± s.e.m. ( h and i ). Individual data points represent biological replicates. Two-tailed t -tests ( b ). One-way ANOVA with Tukey’s multiple comparisons test ( c and d ). Two-way ANOVA genotype × fast with Šidák’s multiple comparisons test ( e and k ). Three-way ANOVA genotype × fast × time ( h – j ). *P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001. g created with BioRender.com .
Intracellular Cgmp Pathway, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/intracellular cgmp pathway/product/MedChemExpress
Average 93 stars, based on 1 article reviews
intracellular cgmp pathway - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Bioss cgmp elisa kit
Schematics showing the design and application of SMP bone screw. (A) Fabrication and shape memory function of SMP bone screw; (B) Schematic illustration of preparation process of SMP-Ca/ArgX (X = 0.5, 1, 2) bone screw; (C) Dopamine-assisted coating of Ca 2+ and Arg's SMP-Ca/Arg screw and subsequent implantation into the bone defect site; (D) SMP-Ca/Arg-P bone screw (an SMP bone screw coated with PDA, Ca 2+ , and 2.0 mg/mL of Arg, and then compressed) can release mechanical force and Arg/Ca 2+ for coupled osteogenesis–angiogenesis in bone repair; (E) Schematic illustration of the forces activate the mechanosensitive transient receptor potential vanilloid 4 (TRPV4) protein and piezo type mechanosensitive ion channel component 2 (PIEZO2). This activation boosts adenosine triphosphate (ATP) generation and enhancing cellular metabolism, facilitating the influx of Ca 2+ and Arg released by the SMP-Ca/Arg bone screws through activated calcium channels (e.g., TRPV4 and PIEZO2) and cell membrane proteins (e.g., cationic amino acid transporter (CAT)). The elevated Ca 2+ level further upregulates calmodulin (CaM) and increase the activity of nitric oxide synthase (NOS) for Arg decomposition to regenerate nitric oxide (NO). This subsequently activates the <t>NO-cGMP</t> pathway, promoting coupled osteogenesis and angiogenesis. The calcium signaling pathway is visually represented by blue arrows, the NO-cGMP pathway is represented by red arrows, and the forces exerted by the SMP-Ca/Arg-P bone screw is indicated by orange arrows.
Cgmp Elisa Kit, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgmp elisa kit/product/Bioss
Average 95 stars, based on 1 article reviews
cgmp elisa kit - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

99
Miltenyi Biotec cgmp grade anti biotin microbeads
Schematics showing the design and application of SMP bone screw. (A) Fabrication and shape memory function of SMP bone screw; (B) Schematic illustration of preparation process of SMP-Ca/ArgX (X = 0.5, 1, 2) bone screw; (C) Dopamine-assisted coating of Ca 2+ and Arg's SMP-Ca/Arg screw and subsequent implantation into the bone defect site; (D) SMP-Ca/Arg-P bone screw (an SMP bone screw coated with PDA, Ca 2+ , and 2.0 mg/mL of Arg, and then compressed) can release mechanical force and Arg/Ca 2+ for coupled osteogenesis–angiogenesis in bone repair; (E) Schematic illustration of the forces activate the mechanosensitive transient receptor potential vanilloid 4 (TRPV4) protein and piezo type mechanosensitive ion channel component 2 (PIEZO2). This activation boosts adenosine triphosphate (ATP) generation and enhancing cellular metabolism, facilitating the influx of Ca 2+ and Arg released by the SMP-Ca/Arg bone screws through activated calcium channels (e.g., TRPV4 and PIEZO2) and cell membrane proteins (e.g., cationic amino acid transporter (CAT)). The elevated Ca 2+ level further upregulates calmodulin (CaM) and increase the activity of nitric oxide synthase (NOS) for Arg decomposition to regenerate nitric oxide (NO). This subsequently activates the <t>NO-cGMP</t> pathway, promoting coupled osteogenesis and angiogenesis. The calcium signaling pathway is visually represented by blue arrows, the NO-cGMP pathway is represented by red arrows, and the forces exerted by the SMP-Ca/Arg-P bone screw is indicated by orange arrows.
Cgmp Grade Anti Biotin Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cgmp grade anti biotin microbeads/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
cgmp grade anti biotin microbeads - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

93
MedChemExpress pcpt cgmp
Schematics showing the design and application of SMP bone screw. (A) Fabrication and shape memory function of SMP bone screw; (B) Schematic illustration of preparation process of SMP-Ca/ArgX (X = 0.5, 1, 2) bone screw; (C) Dopamine-assisted coating of Ca 2+ and Arg's SMP-Ca/Arg screw and subsequent implantation into the bone defect site; (D) SMP-Ca/Arg-P bone screw (an SMP bone screw coated with PDA, Ca 2+ , and 2.0 mg/mL of Arg, and then compressed) can release mechanical force and Arg/Ca 2+ for coupled osteogenesis–angiogenesis in bone repair; (E) Schematic illustration of the forces activate the mechanosensitive transient receptor potential vanilloid 4 (TRPV4) protein and piezo type mechanosensitive ion channel component 2 (PIEZO2). This activation boosts adenosine triphosphate (ATP) generation and enhancing cellular metabolism, facilitating the influx of Ca 2+ and Arg released by the SMP-Ca/Arg bone screws through activated calcium channels (e.g., TRPV4 and PIEZO2) and cell membrane proteins (e.g., cationic amino acid transporter (CAT)). The elevated Ca 2+ level further upregulates calmodulin (CaM) and increase the activity of nitric oxide synthase (NOS) for Arg decomposition to regenerate nitric oxide (NO). This subsequently activates the <t>NO-cGMP</t> pathway, promoting coupled osteogenesis and angiogenesis. The calcium signaling pathway is visually represented by blue arrows, the NO-cGMP pathway is represented by red arrows, and the forces exerted by the SMP-Ca/Arg-P bone screw is indicated by orange arrows.
Pcpt Cgmp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcpt cgmp/product/MedChemExpress
Average 93 stars, based on 1 article reviews
pcpt cgmp - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

99
MaxCyte Inc flow electroporation technology
Schematics showing the design and application of SMP bone screw. (A) Fabrication and shape memory function of SMP bone screw; (B) Schematic illustration of preparation process of SMP-Ca/ArgX (X = 0.5, 1, 2) bone screw; (C) Dopamine-assisted coating of Ca 2+ and Arg's SMP-Ca/Arg screw and subsequent implantation into the bone defect site; (D) SMP-Ca/Arg-P bone screw (an SMP bone screw coated with PDA, Ca 2+ , and 2.0 mg/mL of Arg, and then compressed) can release mechanical force and Arg/Ca 2+ for coupled osteogenesis–angiogenesis in bone repair; (E) Schematic illustration of the forces activate the mechanosensitive transient receptor potential vanilloid 4 (TRPV4) protein and piezo type mechanosensitive ion channel component 2 (PIEZO2). This activation boosts adenosine triphosphate (ATP) generation and enhancing cellular metabolism, facilitating the influx of Ca 2+ and Arg released by the SMP-Ca/Arg bone screws through activated calcium channels (e.g., TRPV4 and PIEZO2) and cell membrane proteins (e.g., cationic amino acid transporter (CAT)). The elevated Ca 2+ level further upregulates calmodulin (CaM) and increase the activity of nitric oxide synthase (NOS) for Arg decomposition to regenerate nitric oxide (NO). This subsequently activates the <t>NO-cGMP</t> pathway, promoting coupled osteogenesis and angiogenesis. The calcium signaling pathway is visually represented by blue arrows, the NO-cGMP pathway is represented by red arrows, and the forces exerted by the SMP-Ca/Arg-P bone screw is indicated by orange arrows.
Flow Electroporation Technology, supplied by MaxCyte Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flow electroporation technology/product/MaxCyte Inc
Average 99 stars, based on 1 article reviews
flow electroporation technology - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

Image Search Results


a , Microarray-based gene expression of lipolytic inhibitors from Fig. in purified mouse adipocytes (C57BL/6J male; GSE27017 , PMID: 23967297) from gWAT (WAT Ad, N = 3) and femur–tibia (rBMAT and cBMAT mix—BMAd, N = 3) and human adipocytes (mixed male and female, aged 53–87 years; PMID: 28574591) from subcutaneous adipose tissue (WAT Ad, N = 3) and femoral head (rBMAT and cBMAT mix—BMAd, N = 3). Arrows indicate expression of candidate lipolysis inhibitor G0s2 . b , Ratio of ATGL-inhibitor G0s2 to ATGL ( Pnpla2 ) in purified mouse adipocytes as in a fed chow (6, 14, and 18 months, N = 3 per group) or a high-fat diet (HFD; 6 and 14 months, N = 3/group). c , Ratio in human purified bone marrow stromal cells (BMSCs) from femoral head and adipocytes as in a ( N = 3 per group). d , Ratio in mouse cBMAT-filled CV with males and females combined ( N = 10 ICV PBS, N = 12 ICV leptin, N = 6 ICV leptin + subcutaneous insulin pellet). Dotted line, average value for iWAT. ins, insulin; Lep, leptin. e – h , Female 11–12-week-old WT control littermates and adipocyte-specific G0s2 KO mice (WT fed N = 6, WT 24-h fast N = 5, cKO fed N = 7, cKO fast N = 5). BMAT quantification ( e ) with representative images; bone is shown in light grey with BMAT in dark grey ( f ). Whole CV were rapidly extracted and quartered with immediate placement in lipolysis stimulation buffer containing 5 µM FSK, 10 mM 8-bromo or vehicle control (2 × CV per mouse per treatment condition in 150 µl in a 96-well plate). Plates were incubated at 37°C in 5% CO 2 with samples taken for glycerol measurement after 1.5 and 4.0 h ( g ). Percentage change in glycerol release over time relative to vehicle control for cBMAT-filled CV ( h ). i , We treated 10 mg of iWAT per 150 µl in a 96-well plate from the same animals as described in g as a positive control. j , k , Body mass ( j ) and iWAT mass ( k ) are from the same animals. Mean ± standard deviation ( a – e , j and k ). Mean ± s.e.m. ( h and i ). Individual data points represent biological replicates. Two-tailed t -tests ( b ). One-way ANOVA with Tukey’s multiple comparisons test ( c and d ). Two-way ANOVA genotype × fast with Šidák’s multiple comparisons test ( e and k ). Three-way ANOVA genotype × fast × time ( h – j ). *P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001. g created with BioRender.com .

Journal: Nature Metabolism

Article Title: A catecholamine-independent pathway controlling adaptive adipocyte lipolysis

doi: 10.1038/s42255-025-01424-5

Figure Lengend Snippet: a , Microarray-based gene expression of lipolytic inhibitors from Fig. in purified mouse adipocytes (C57BL/6J male; GSE27017 , PMID: 23967297) from gWAT (WAT Ad, N = 3) and femur–tibia (rBMAT and cBMAT mix—BMAd, N = 3) and human adipocytes (mixed male and female, aged 53–87 years; PMID: 28574591) from subcutaneous adipose tissue (WAT Ad, N = 3) and femoral head (rBMAT and cBMAT mix—BMAd, N = 3). Arrows indicate expression of candidate lipolysis inhibitor G0s2 . b , Ratio of ATGL-inhibitor G0s2 to ATGL ( Pnpla2 ) in purified mouse adipocytes as in a fed chow (6, 14, and 18 months, N = 3 per group) or a high-fat diet (HFD; 6 and 14 months, N = 3/group). c , Ratio in human purified bone marrow stromal cells (BMSCs) from femoral head and adipocytes as in a ( N = 3 per group). d , Ratio in mouse cBMAT-filled CV with males and females combined ( N = 10 ICV PBS, N = 12 ICV leptin, N = 6 ICV leptin + subcutaneous insulin pellet). Dotted line, average value for iWAT. ins, insulin; Lep, leptin. e – h , Female 11–12-week-old WT control littermates and adipocyte-specific G0s2 KO mice (WT fed N = 6, WT 24-h fast N = 5, cKO fed N = 7, cKO fast N = 5). BMAT quantification ( e ) with representative images; bone is shown in light grey with BMAT in dark grey ( f ). Whole CV were rapidly extracted and quartered with immediate placement in lipolysis stimulation buffer containing 5 µM FSK, 10 mM 8-bromo or vehicle control (2 × CV per mouse per treatment condition in 150 µl in a 96-well plate). Plates were incubated at 37°C in 5% CO 2 with samples taken for glycerol measurement after 1.5 and 4.0 h ( g ). Percentage change in glycerol release over time relative to vehicle control for cBMAT-filled CV ( h ). i , We treated 10 mg of iWAT per 150 µl in a 96-well plate from the same animals as described in g as a positive control. j , k , Body mass ( j ) and iWAT mass ( k ) are from the same animals. Mean ± standard deviation ( a – e , j and k ). Mean ± s.e.m. ( h and i ). Individual data points represent biological replicates. Two-tailed t -tests ( b ). One-way ANOVA with Tukey’s multiple comparisons test ( c and d ). Two-way ANOVA genotype × fast with Šidák’s multiple comparisons test ( e and k ). Three-way ANOVA genotype × fast × time ( h – j ). *P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001. g created with BioRender.com .

Article Snippet: Wells contained 150 μl solution as follows: first well, vehicle treatment (Hank’s Balanced Salt Solution + 2% fatty acid-free BSA + 1:500 dimethylsulfoxide vehicle control); second well, the same as the first well with 5 μM FSK (Cayman Chemical, 66575-29-9); and the third well, the same as the first well with 10 mM 8-bromo cAMP (MedChemExpress, HY-101379A).

Techniques: Microarray, Gene Expression, Purification, Expressing, Control, Incubation, Positive Control, Standard Deviation, Two Tailed Test

Schematics showing the design and application of SMP bone screw. (A) Fabrication and shape memory function of SMP bone screw; (B) Schematic illustration of preparation process of SMP-Ca/ArgX (X = 0.5, 1, 2) bone screw; (C) Dopamine-assisted coating of Ca 2+ and Arg's SMP-Ca/Arg screw and subsequent implantation into the bone defect site; (D) SMP-Ca/Arg-P bone screw (an SMP bone screw coated with PDA, Ca 2+ , and 2.0 mg/mL of Arg, and then compressed) can release mechanical force and Arg/Ca 2+ for coupled osteogenesis–angiogenesis in bone repair; (E) Schematic illustration of the forces activate the mechanosensitive transient receptor potential vanilloid 4 (TRPV4) protein and piezo type mechanosensitive ion channel component 2 (PIEZO2). This activation boosts adenosine triphosphate (ATP) generation and enhancing cellular metabolism, facilitating the influx of Ca 2+ and Arg released by the SMP-Ca/Arg bone screws through activated calcium channels (e.g., TRPV4 and PIEZO2) and cell membrane proteins (e.g., cationic amino acid transporter (CAT)). The elevated Ca 2+ level further upregulates calmodulin (CaM) and increase the activity of nitric oxide synthase (NOS) for Arg decomposition to regenerate nitric oxide (NO). This subsequently activates the NO-cGMP pathway, promoting coupled osteogenesis and angiogenesis. The calcium signaling pathway is visually represented by blue arrows, the NO-cGMP pathway is represented by red arrows, and the forces exerted by the SMP-Ca/Arg-P bone screw is indicated by orange arrows.

Journal: Bioactive Materials

Article Title: Shape memory bone screws loading L-arginine and Ca 2+ propagate mechanical stimulation, energize bone cells and augment bone regeneration

doi: 10.1016/j.bioactmat.2025.07.007

Figure Lengend Snippet: Schematics showing the design and application of SMP bone screw. (A) Fabrication and shape memory function of SMP bone screw; (B) Schematic illustration of preparation process of SMP-Ca/ArgX (X = 0.5, 1, 2) bone screw; (C) Dopamine-assisted coating of Ca 2+ and Arg's SMP-Ca/Arg screw and subsequent implantation into the bone defect site; (D) SMP-Ca/Arg-P bone screw (an SMP bone screw coated with PDA, Ca 2+ , and 2.0 mg/mL of Arg, and then compressed) can release mechanical force and Arg/Ca 2+ for coupled osteogenesis–angiogenesis in bone repair; (E) Schematic illustration of the forces activate the mechanosensitive transient receptor potential vanilloid 4 (TRPV4) protein and piezo type mechanosensitive ion channel component 2 (PIEZO2). This activation boosts adenosine triphosphate (ATP) generation and enhancing cellular metabolism, facilitating the influx of Ca 2+ and Arg released by the SMP-Ca/Arg bone screws through activated calcium channels (e.g., TRPV4 and PIEZO2) and cell membrane proteins (e.g., cationic amino acid transporter (CAT)). The elevated Ca 2+ level further upregulates calmodulin (CaM) and increase the activity of nitric oxide synthase (NOS) for Arg decomposition to regenerate nitric oxide (NO). This subsequently activates the NO-cGMP pathway, promoting coupled osteogenesis and angiogenesis. The calcium signaling pathway is visually represented by blue arrows, the NO-cGMP pathway is represented by red arrows, and the forces exerted by the SMP-Ca/Arg-P bone screw is indicated by orange arrows.

Article Snippet: Similarly, on day 3, the cGMP ELISA kit (Bioss, China) was used to measure the amount of cGMP.

Techniques: Activation Assay, Membrane, Activity Assay

In vitro osteogenesis and angiogenesis potential of SMP bone screw. (A) Schematic illustration showing the released Ca 2+ and Arg synergistically activate the NO-cGMP pathway, ultimately promoting both osteogenesis and angiogenesis. Release profiles of (B) Ca 2+ and (C) Arg from different SMP bone screws. (D) Representative ALP staining images (with enlarged images inserted) and (E) quantitative analysis of ALP activity of rBMSCs on day 3 and day 7. (F) Representative ARS images and (G) quantitative analysis of calcium deposition of rBMSCs on day 7 and day 14. (H) Representative fluorescence images showing the endothelial network formation in HUVECs after co-culture for 6 and 12 h. (I-K) Relative expression of angiogenic-related gene expression including eNOS, nitrite levels, and cGMP concentration of rBMSCs and HUVECs on day 3. Data were presented as mean ± SD and analyzed by one-way ANOVA (n = 3 for each sample, ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001). These results suggest that Ca 2+ and Arg synergistically activate the NO-cGMP signaling pathway to promote osteogenesis and angiogenesis.

Journal: Bioactive Materials

Article Title: Shape memory bone screws loading L-arginine and Ca 2+ propagate mechanical stimulation, energize bone cells and augment bone regeneration

doi: 10.1016/j.bioactmat.2025.07.007

Figure Lengend Snippet: In vitro osteogenesis and angiogenesis potential of SMP bone screw. (A) Schematic illustration showing the released Ca 2+ and Arg synergistically activate the NO-cGMP pathway, ultimately promoting both osteogenesis and angiogenesis. Release profiles of (B) Ca 2+ and (C) Arg from different SMP bone screws. (D) Representative ALP staining images (with enlarged images inserted) and (E) quantitative analysis of ALP activity of rBMSCs on day 3 and day 7. (F) Representative ARS images and (G) quantitative analysis of calcium deposition of rBMSCs on day 7 and day 14. (H) Representative fluorescence images showing the endothelial network formation in HUVECs after co-culture for 6 and 12 h. (I-K) Relative expression of angiogenic-related gene expression including eNOS, nitrite levels, and cGMP concentration of rBMSCs and HUVECs on day 3. Data were presented as mean ± SD and analyzed by one-way ANOVA (n = 3 for each sample, ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001). These results suggest that Ca 2+ and Arg synergistically activate the NO-cGMP signaling pathway to promote osteogenesis and angiogenesis.

Article Snippet: Similarly, on day 3, the cGMP ELISA kit (Bioss, China) was used to measure the amount of cGMP.

Techniques: In Vitro, Staining, Activity Assay, Fluorescence, Co-Culture Assay, Expressing, Gene Expression, Concentration Assay

Bioinformatic analysis of gene expression of rMSCs on different bone screws. (A) Principal component analysis of gene expression profile of rMSCs grown in the presence of cSMP screw or SMP-Ca/Arg2-P screw; (B) Venn diagram illustration of the significant DEGs between the SMP-Ca/Arg2-P group and the cSMP group; (C) Volcano plots of transcriptomic analysis of DEGs in cSMP versus SMP-Ca/Arg2-P; (D) Up-regulated enriched Kyoto Encyclopedia of Genes and Genomes pathways of cSMP versus SMP-Ca/Arg2-P; (E) Heatmap evaluation of up-regulated DEGs involved in mechanosensitive calcium, PI3K-Akt and cGMP-PKG signaling pathways; (F-G) Relative messenger RNA expression evaluation of targeted genes via qRT-PCR; (H) Schematic illustration of potential SMP-Ca/Arg2-P-mediated activation of the mechanosensitive and NO-cGMP signaling pathway for coupling osteogenesis-angiogenesis. Sample size n = 3 for all experiments. Data were presented as mean ± SD and analyzed by one-way ANOVA ( n = 6 for each sample, ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001).

Journal: Bioactive Materials

Article Title: Shape memory bone screws loading L-arginine and Ca 2+ propagate mechanical stimulation, energize bone cells and augment bone regeneration

doi: 10.1016/j.bioactmat.2025.07.007

Figure Lengend Snippet: Bioinformatic analysis of gene expression of rMSCs on different bone screws. (A) Principal component analysis of gene expression profile of rMSCs grown in the presence of cSMP screw or SMP-Ca/Arg2-P screw; (B) Venn diagram illustration of the significant DEGs between the SMP-Ca/Arg2-P group and the cSMP group; (C) Volcano plots of transcriptomic analysis of DEGs in cSMP versus SMP-Ca/Arg2-P; (D) Up-regulated enriched Kyoto Encyclopedia of Genes and Genomes pathways of cSMP versus SMP-Ca/Arg2-P; (E) Heatmap evaluation of up-regulated DEGs involved in mechanosensitive calcium, PI3K-Akt and cGMP-PKG signaling pathways; (F-G) Relative messenger RNA expression evaluation of targeted genes via qRT-PCR; (H) Schematic illustration of potential SMP-Ca/Arg2-P-mediated activation of the mechanosensitive and NO-cGMP signaling pathway for coupling osteogenesis-angiogenesis. Sample size n = 3 for all experiments. Data were presented as mean ± SD and analyzed by one-way ANOVA ( n = 6 for each sample, ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001).

Article Snippet: Similarly, on day 3, the cGMP ELISA kit (Bioss, China) was used to measure the amount of cGMP.

Techniques: Gene Expression, Protein-Protein interactions, RNA Expression, Quantitative RT-PCR, Activation Assay